日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats

在猫身上同时局部应用氟雷拉纳、莫昔克丁和吡喹酮的安全性

Walther, Feli M; Fisara, Petr; Roepke, Rainer K A

Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel

同时使用氟雷拉纳和依莫普西-吡喹酮治疗猫的安全性

Walther, Feli M; Allan, Mark J; Roepke, Rainer K A

Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel

勘误:同时使用氟雷拉纳和依莫德普西-吡喹酮治疗猫的安全性

Walther, Feli M; Allan, Mark J; Roepke, Rainer K A

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs

犬同时服用氟雷拉纳(Bravecto™)和伊维菌素后的血浆药代动力学特征

Walther, Feli M; Allan, Mark J; Roepke, Rainer K A

Safety of the concurrent treatment of dogs with Bravecto (fluralaner) and Scalibor protectorband (deltamethrin)

同时使用 Bravecto(氟雷拉纳)和 Scalibor protectorband(溴氰菊酯)治疗犬只的安全性

Walther, Feli M; Fisara, Petr; Allan, Mark J; Roepke, Rainer K A; Nuernberger, Martin C

The effect of food on the pharmacokinetics of oral fluralaner in dogs

食物对犬口服氟雷拉纳药代动力学的影响

Walther, Feli M; Allan, Mark J; Roepke, Rainer K A; Nuernberger, Martin C

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

口服新型全身性抗寄生虫药物氟雷拉纳后,在MDR1(-/-)柯利犬中的安全性

Walther, Feli M; Paul, Allan J; Allan, Mark J; Roepke, Rainer K A; Nuernberger, Martin C

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime-praziquantel

同时使用氟雷拉纳(Bravecto™)和米尔贝肟-吡喹酮治疗犬的安全性

Walther, Feli M; Fisara, Petr; Allan, Mark J; Roepke, Rainer K A; Nuernberger, Martin C

Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration

氟雷拉纳咀嚼片(Bravecto)是一种新型全身性抗寄生虫药物,口服给药后在犬体内的安全性

Walther, Feli M; Allan, Mark J; Roepke, Rainer K A; Nuernberger, Martin C